Additionally, the activation of the PI3K/Akt pathway with interaction with AR, which shows some prognostic impact in SDC, implies that it has the potential to be a biomarker of tumor aggressiveness, which may be useful for selecting hormonal and targeted therapy. Here, AR is linked to neoplasm.